Phio Pharmaceuticals Corp. (PHIO) Misses Q2 EPS by 6c

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q2 EPS of ($0.36), $0.06 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
• JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight